Neurocognitive Function clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18 years and up
In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.
Our lead scientists for Neurocognitive Function research studies include Jona Hattangadi-Gluth, MD.